Skip to main content
Clinical Trials/ISRCTN01133608
ISRCTN01133608
Completed
Not Applicable

A randomised double-blind placebo-controlled study of energy, protein and micronutrients supplementation of elderly patients in active rehabilitation settings

The Health Foundation (UK)0 sites445 target enrollmentSeptember 12, 2002

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
utritional status in the elderly
Sponsor
The Health Foundation (UK)
Enrollment
445
Status
Completed
Last Updated
11 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 12, 2002
End Date
TBD
Last Updated
11 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
The Health Foundation (UK)

Eligibility Criteria

Inclusion Criteria

  • Patients will be eligible for the study if they meet the following criteria:
  • 1\. Age 65 years, stable medical condition, referred for an active rehabilitation program
  • 2\. Able to swallow
  • 3\. Able to sign an informed written consent form

Exclusion Criteria

  • Not provided at time of registration

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
A randomised double-blind placebo-controlled study to investigate the possible role of Opiate Morphine (MST) in the treatment of chronic cough.
ISRCTN18474014Record Provided by the NHSTCT Register - 2004 Update - Department of Health (UK)30
Completed
Phase 3
A randomised double-blind placebo-controlled study to evaluate the effect ofcurcumin on BDNF levels in otherwise healthy adults.Brain-Derived Neurotrophic Factor in healthy adultsNeurological - Studies of the normal brain and nervous systemAlternative and Complementary Medicine - Other alternative and complementary medicine
ACTRN12621000104853RDC Global Pty Ltd69
Completed
Not Applicable
A randomised double-blind placebo controlled study of adenosine given as a Bier's block for patients with neuropathic pain in the limbsSigns and Symptoms: PainSigns and SymptomsPain
ISRCTN86618747Record provided by the NHS Trusts Clinical Trials Register - Department of Health (UK)30
Not yet recruiting
Phase 1
Effect PartySmart Variants in alcohol subjects.
CTRI/2021/03/032236The Himalaya Drug Company
Completed
Phase 2
A double-blind randomised placebo controlled study to evaluate the effects of different doses of testosterone from a Testosterone Metered-Dose Transdermal Spray (MDTS) on sexual function in premenopausal women with low libidoow libido in post menopausal women suffering from low serum testosteroneLow libido in post menopausal women suffering from low serum testosteroneReproductive Health and Childbirth - Menstruation and menopause
ACTRN12605000481673FemPharm Pty Ltd and/or Acrux DDS Pty Ltd200